Results 101 to 110 of about 1,565 (154)

A pharmacoinformatic approach for studying Atractylodes Lancea DC's anticancer potential and control ROS-mediated apoptosis against prostate cancer cells. [PDF]

Front Oncol
Ahn CH, Myong JS, Ahmed KR, Rahman MA, Fahim MMH, Choi M, Rahman M, Choi J, Kim K, Moon S, Dalli M, Syahputra RA, Shin SW, Harrath AH, Park MN, Kim B, Yoo HS.   +16 more
europepmc   +1 more source

Population-pharmacokinetic/pharmacodynamic model of atractylodes lancea (Thunb.) DC. administration in patients with advanced-stage intrahepatic cholangiocarcinoma: a dosage prediction. [PDF]

BMC Complement Med Ther
Saeheng T, Karbwang J, Na-Bangchang K.
europepmc   +1 more source

Genome resequencing reveals the genetic basis of population evolution, local adaptation, and rewiring of the rhizome metabolome in Atractylodes lancea. [PDF]

Hortic Res
Zhang C, Wang S, Sun J, Li X, Wang H, Guo X, Wang Y, Jiang D, Lyu C, Kang C, Zhang Y, Xiang Z, Yuan Q, Yan B, Qin M, Huang L, Guo L.   +16 more
europepmc   +1 more source

<i>Atractylodes lancea</i> (Thunb.) DC. [Asteraceae] Rhizome-Derived Exosome-like Nanoparticles Suppress Lipopolysaccharide-Induced Inflammation by Reducing Toll-like Receptor 4 Expression in BV-2 Murine Microglial Cells. [PDF]

Pharmaceuticals (Basel)
Hyodo M, Kawada K, Ishida T, Izawa-Ishizawa Y, Matoba R, Okamoto R, Jobu K, Horikawa I, Aizawa F, Yagi K, Niimura T, Kawano Y, Abe S, Hamada Y, Goda M, Ishizawa K.   +15 more
europepmc   +1 more source

Atractylodes lancea (Thunb.) DC. [Asteraceae] rhizome-derived exosome-like nanoparticles suppress lipopolysaccharide-induced inflammation in murine microglial cells. [PDF]

Front Pharmacol
Kawada K, Ishida T, Morisawa S, Jobu K, Higashi Y, Aizawa F, Yagi K, Izawa-Ishizawa Y, Niimura T, Abe S, Goda M, Miyamura M, Ishizawa K.   +12 more
europepmc   +1 more source

The investigation of thermal stability and GC-MS analysis of Acorus tatarinowii and Atractylodes lancea volatile oils treated by β cyclodextrin inclusion and Pickering emulsion technologies. [PDF]

Heliyon
Chen ZY, Shi YJ, Zhang XF, Luan F, Guo DY, Sun J, Zhai BT, Zhang DK, Jun-Bo Zou.   +8 more
europepmc   +1 more source

Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of <i>Atractylodes lancea</i> (Thunb) DC. [PDF]

Integr Cancer Ther
Saeheng T, Karbwang J, Cheomung A, Tongsiri N, Plengsuriyakarn T, Na-Bangchang K.   +5 more
europepmc   +1 more source

Corrigendum to "Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of Atractylodes lancea (Thunb) DC". [PDF]

Integr Cancer Ther
europepmc   +1 more source

Glycosides of Atractylodes lancea

Chemical and Pharmaceutical Bulletin, 2003
Five sesquiterpenoid glycosides (two guaiane-type glycosides and three eudesmane-type glucosides) and a glucoside of an acetylene derivative were newly isolated from the water-soluble portion of the methanolic extract of Atractylodes lancea rhizome together with 26 known compounds.
Junichi Kitajima, Yoshiteru Ida, Akihito Takano   +2 more
exaly   +3 more sources